Physiology of natural killer cells. In vivo regulation of progenitors by interleukin 3
- PMID: 3500227
Physiology of natural killer cells. In vivo regulation of progenitors by interleukin 3
Abstract
Adoptive transfer of bone marrow cells to syngeneic lethally irradiated C57BL/6 mice was used to study the maturation of natural killer (NK) cells from their progenitors. The NK progenitor cell was found to be asialomonoganglioside-negative, (aGM1-) Thy-1-, NK-1-, Ly-1-, Ly-2-, and L3T4-. The NK cells emerging from the bone marrow grafts were aGM1+, NK-1+, Thy-1+/-, Ly-1-, Ly-2-, and L3T4- and to have a target specter similar to that of NK cells isolated from the spleen of normal mice. The regulatory role of interleukin 2 (IL-2) and interleukin 3 (IL-3) for the maturation of NK cells was examined by exposure of the bone marrow cells to the lymphokines in vitro before bone marrow grafting or by treatment of bone marrow-grafted mice with lymphokines through s.c. implanted miniosmotic pumps. IL-3 antagonized the IL-2-induced maturation of NK cells in vitro and strongly inhibited the generation of NK cells after adoptive transfer of bone marrow cells in vivo. The suppressive effect of IL-3 was evident throughout the treatment period (8 or 16 days) but was apparently reversible because NK activity returned to control levels within 8 days after cessation of treatment. The inhibition of cytotoxic activity was accompanied by a reduced appearance of cells with the NK phenotypic markers aGM1 or NK-1, indicating that not only the cytotoxic activity of NK cells but also their actual formation was inhibited. Concomitantly, a moderate increase in cells expressing the T cell marker L3T4 and an increased proliferative response to the T cell mitogen concanavalin A was observed. A direct estimate of the effect of IL-3 on the frequency of NK cell progenitors was obtained by limiting dilution analysis of bone marrow cells at day 8 after bone marrow transplantation. The estimated minimal frequency of NK cell progenitors was reduced from 1/11,800 in control to 1/41,900 in IL-3-exposed mice. IL-3 may take part in the homeostasis of NK cells by the down-regulation of their progenitors.
Similar articles
-
Interleukin 3 is a major negative regulator of the generation of natural killer cells from bone marrow precursors.J Immunol. 1986 Oct 1;137(7):2268-71. J Immunol. 1986. PMID: 2876040
-
Generation of natural killer cells from bone marrow precursors in vitro.Immunology. 1986 Apr;57(4):493-8. Immunology. 1986. PMID: 3485566 Free PMC article.
-
Regulation of natural killer progenitors. Studies with a novel immunomodulator with distinct effects at the precursor level.J Immunol. 1990 Jun 1;144(11):4472-6. J Immunol. 1990. PMID: 2341727
-
Human natural killer cell development from bone marrow progenitors: analysis of phenotype, cytotoxicity and growth.Nat Immun. 1993 Jul-Oct;12(4-5):209-17. Nat Immun. 1993. PMID: 8257827 Review.
-
Stromal-cell regulation of natural killer cell differentiation.J Mol Med (Berl). 2007 Oct;85(10):1047-56. doi: 10.1007/s00109-007-0195-0. Epub 2007 Apr 11. J Mol Med (Berl). 2007. PMID: 17426948 Review.
Cited by
-
Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection.Agents Actions. 1991 Jan;32(1-2):10-21. doi: 10.1007/BF01983301. Agents Actions. 1991. PMID: 2058454 Review.
-
Interleukin-3 and interleukin-4 each strongly inhibit the induction and function of human LAK cells.Clin Exp Immunol. 1988 Nov;74(2):166-70. Clin Exp Immunol. 1988. PMID: 3265653 Free PMC article.
-
Medullasin induces activated killer cells from human lymphocytes.Jpn J Cancer Res. 1988 Jun;79(6):687-90. doi: 10.1111/j.1349-7006.1988.tb02223.x. Jpn J Cancer Res. 1988. PMID: 3137194 Free PMC article.
-
Cytokines regulate the ability of human LAK-cells to kill human tumour cells in vitro.Br J Cancer. 1989 Jun;59(6):919-21. doi: 10.1038/bjc.1989.194. Br J Cancer. 1989. PMID: 2660898 Free PMC article. No abstract available.
-
Biology of natural killer cells.Adv Immunol. 1989;47:187-376. doi: 10.1016/s0065-2776(08)60664-1. Adv Immunol. 1989. PMID: 2683611 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous